All Clinical Trials in Canada

A listing of 3910 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

NCT06133972

Recruiting

The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously completed the treatment period in one of the two SIRIUS-SLE core studies (CVAY736F12301 or CVAY736F12302).

Gender:

ALL

Ages:

Between 12 years and 100 years

Trial Updated:

07/29/2025

Locations: Pinnacle Research Group Llc, Anniston, Alabama +79 locations

Pinnacle Research Group Llc, Anniston, Alabama

Advanced Medical Research, La Palma, California

Millennium Clinical Trials, Westlake Village, California

Clinical Res Of W Florida, Clearwater, Florida

Accurate Clinical Research, Lake Charles, Louisiana

University Of Maryland Med Ctr, Baltimore, Maryland

Ahmed Arif Medical Research Center, Grand Blanc, Michigan

West Tennessee Research Institute, Jackson, Tennessee

Shelby Research LLC, Memphis, Tennessee

Novel Research LLC, Bellaire, Texas

Novartis Investigative Site, Ciudad Autonoma de Bs As, Buenos Aires

Novartis Investigative Site, San Miguel, Buenos Aires

Novartis Investigative Site, San Miguel de Tucuman, Tucuman

Novartis Investigative Site, Tucuman, Not set

Novartis Investigative Site, Maroochydore, Queensland

Novartis Investigative Site, Salvador, BA

Novartis Investigative Site, Belo Horizonte, MG

Novartis Investigative Site, Barretos, Sao Paulo

Novartis Investigative Site, Sao Paulo, SP

Novartis Investigative Site, Plovdiv, Not set

Novartis Investigative Site, Rimouski, Quebec

Novartis Investigative Site, Guangzhou, Guangdong

Novartis Investigative Site, Shantou, Guangdong

Novartis Investigative Site, Nanjing, Jiangsu

Novartis Investigative Site, Suzhou, Jiangsu

Novartis Investigative Site, Nanchang, Jiangxi

Novartis Investigative Site, Pingxiang, Jiangxi

Novartis Investigative Site, Chang Chun, Jilin

Novartis Investigative Site, Linyi, Shandong

Novartis Investigative Site, Urumqi, Xinjiang

Novartis Investigative Site, Beijing, Not set

Novartis Investigative Site, Shanghai, Not set

Novartis Investigative Site, Zhejiang, Not set

Novartis Investigative Site, Medellin, Antioquia

Novartis Investigative Site, Barranquilla, Atlantico

Novartis Investigative Site, Chia, Cundinamarca

Novartis Investigative Site, Bucaramanga, Santander

Novartis Investigative Site, Bogota, Not set

Novartis Investigative Site, Brno, Not set

Novartis Investigative Site, Uherske Hradiste, Not set

Novartis Investigative Site, Montpellier 5, Not set

Novartis Investigative Site, Paris, Not set

Novartis Investigative Site, Leipzig, Sachsen

Novartis Investigative Site, Guatemala City, Not set

Novartis Investigative Site, Guatemala, Not set

Novartis Investigative Site, Szekesfehervar, Fejer

Novartis Investigative Site, Ahmedabad, Gujarat

Novartis Investigative Site, Ramat Gan, Not set

Novartis Investigative Site, Torino, TO

Novartis Investigative Site, Nagoya, Aichi

Novartis Investigative Site, Sapporo city, Hokkaido

Novartis Investigative Site, Seoul, Seocho Gu

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Ipoh, Perak

Novartis Investigative Site, Ciudad de Mexico, Distrito Federal

Novartis Investigative Site, Leon, Guanajuato

Novartis Investigative Site, Guadalajara, Jalisco

Novartis Investigative Site, Merida, Yucatan

Novartis Investigative Site, Mexico, Not set

Novartis Investigative Site, Wroclaw, Dolnoslaskie

Novartis Investigative Site, Bydgoszcz, Not set

Novartis Investigative Site, Bytom, Not set

Novartis Investigative Site, Warszawa, Not set

Novartis Investigative Site, Braga, Not set

Novartis Investigative Site, Brasov, Not set

Novartis Investigative Site, Cluj Napoca, Not set

Novartis Investigative Site, Santander, Cantabria

Novartis Investigative Site, Badalona, Catalunya

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, Santiago De Compostela, Galicia

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, Kaohsiung, Not set

Novartis Investigative Site, Taichung, Not set

Novartis Investigative Site, Taoyuan, Not set

Novartis Investigative Site, Bangkok, Not set

Conditions: Systemic Lupus Erythematosus

Learn More ›

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490

Recruiting

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/29/2025

Locations: Local Institution - 0050, Scottsdale, Arizona +48 locations

Local Institution - 0050, Scottsdale, Arizona

Local Institution - 0017, Aurora, Colorado

Local Institution - 0015, Tampa, Florida

Local Institution - 0016, Kansas City, Kansas

Neurology Center of New England, Foxboro, Massachusetts

Local Institution - 0018, Saint Louis, Missouri

University of Cincinnati Medical Center, Cincinnati, Ohio

Local Institution - 0039, Columbus, Ohio

Hope Neurology, Knoxville, Tennessee

Local Institution - 0001, Kirkland, Washington

Local Institution - 0005, Newcastle, New South Wales

Local Institution - 0004, Sydney, New South Wales

Local Institution - 0030, Kent Town, South Australia

Local Institution - 0007, Box Hill, Victoria

Austin Health, Heidelberg, Victoria

Local Institution - 0006, Parkville, Victoria

Perron Institute, Nedlands, Western Australia

Local Institution - 0013, Edmonton, Alberta

Local Institution - 0024, London, Ontario

Local Institution - 0012, Ottawa, Ontario

Local Institution - 0028, Toronto, Ontario

Local Institution - 0014, Lévis, Quebec

Local Institution - 0029, Montreal, Quebec

Local Institution - 0055, Brno, Brno-město

Local Institution - 0010, Hradec Kralove, Hradec Králové

Local Institution - 0054, Prague, Praha 2

Local Institution - 0059, Prague, Praha 4

Local Institution - 0011, Praha, Praha 5

Local Institution - 0053, Pardubice, Not set

Local Institution - 0009, Teplice, Ústecký Kraj

Local Institution - 0052, Wuerzburg, Bayern

Local Institution - 0022, Kassel, Hessen

Local Institution - 0027, Bochum, Nordrhein-Westfalen

Local Institution - 0060, Münster, Nordrhein-Westfalen

Local Institution - 0031, Meisenheim, Rheinland-Pfalz

Local Institution - 0023, Jena, Thüringen

Local Institution - 0051, Bielefeld, Not set

Local Institution - 0021, Dresden, Not set

Local Institution - 0020, Essen, Not set

Local Institution - 0057, Bydgoszcz, Kujawsko-pomorskie

Local Institution - 0044, Bydgoszcz, Kujawsko-pomorskie

Local Institution - 0046, Kraków, Małopolskie

Local Institution - 0056, Kraków, Małopolskie

Local Institution - 0048, Oswiecim, Małopolskie

Local Institution - 0047, Warszawa, MZ

Local Institution - 0061, Gdańsk, Not set

Local Institution - 0051, Slomniki, Not set

Local Institution - 0045, Katowice, Śląskie

Puerto Rico Multiple Sclerosis Center, Caguas, Not set

Conditions: Multiple Sclerosis Spasticity

Learn More ›

Study to Assess the Safety, Tolerability, PK and PD of ABX1100

NCT06109948

Recruiting

Study ABX1100-1001 is a first-in-human (FIH), phase 1 study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of a single ascending dose (SAD) and multiple doses (MD) of ABX1100 administered intravenously to healthy participants and patients with LOPD. * Part A features a SAD study with a double-blind, placebo-controlled, randomized design in NHVs involving 3 cohorts (A1-A3). This Part also includes a single dose, open-labeled cohort (A4) in NHVs which will commence afte... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: UCI, Orange, California +4 locations

Conditions: Healthy, Late Onset Pompe Disease

Learn More ›

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

NCT03242642

Recruiting

Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: University of Alabama Birmingham (UAB), Birmingham, Alabama +84 locations

University of Alabama Birmingham (UAB), Birmingham, Alabama

Abrazo Heart Hospital, Phoenix, Arizona

Scripps Memorial Hospital, La Jolla, California

PIH Health Good Samaritan Hospital, Los Angeles, California

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

Keck Hospital of the University of Southern California, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

El Camino, Mountain View, California

Kaiser Permanente San Francisco Medical Center, San Francisco, California

Stanford Hospital and Clinics, Stanford, California

Los Robles Regional Medical Center, Thousand Oaks, California

Hartford Hospital, Hartford, Connecticut

Yale New Haven Hospital, New Haven, Connecticut

MedStar Washington Hospital Center, Washington, District of Columbia

JFK Medical Center, Atlantis, Florida

Morton Plant, Clearwater, Florida

HealthPark Medical Center, Fort Myers, Florida

North Florida Regional Medical Center, Gainesville, Florida

Baptist Medical Center Jacksonville, Jacksonville, Florida

University of South Florida, Tampa, Florida

Emory University, Atlanta, Georgia

Piedmont Atlanta Hospital, Atlanta, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

Rush University Medical Center, Chicago, Illinois

Mercy Medical Center, Des Moines, Iowa

The University of Kansas Hospital, Kansas City, Kansas

University of Maryland Medical Center, Baltimore, Maryland

The Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

University of Michigan Health System, Ann Arbor, Michigan

Henry Ford Saint John Hospital, Detroit, Michigan

Corewell Health, Grand Rapids, Michigan

Abbott Northwestern Hospital, Minneapolis, Minnesota

M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis, Minnesota

Barnes-Jewish Hospital, Saint Louis, Missouri

Providence St Patrick, Missoula, Montana

Morristown Medical Center, Morristown, New Jersey

Jersey Shore University Medical Center, Neptune, New Jersey

North Shore University Hospital, Manhasset, New York

NYU Langone Hospital - Long Island, Mineola, New York

NYU Langone Medical Center, New York, New York

The Mount Sinai Hospital, New York, New York

New York-Presbyterian Hospital Columbia University Medical Center, New York, New York

Montefiore Medical Center, New York, New York

Saint Francis Hospital, Roslyn, New York

Duke University Medical Center, Durham, North Carolina

The Christ Hospital, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

The Ohio State University Wexner Medical Center, Columbus, Ohio

OhioHealth Riverside Methodist Hospital, Columbus, Ohio

INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma

Providence Saint Vincent Medical Center, Portland, Oregon

Oregon Health and Science University, Portland, Oregon

UPMC Pinnacle Harrisburg Campus, Harrisburg, Pennsylvania

University of Pittsburgh Medical Center UPMC Presbyterian, Pittsburgh, Pennsylvania

Lankenau Medical Center, Wynnewood, Pennsylvania

Vanderbilt University Medical Center, Nashville, Tennessee

Heart Hospital of Austin, Austin, Texas

Texas Health Presbyterian Hospital Dallas, Dallas, Texas

Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas

CHI Saint Luke's Health-Baylor Saint Luke's Medical Center, Houston, Texas

Houston Methodist Hospital, Houston, Texas

The University of Texas Health Science Center at Houston, Houston, Texas

Baylor Scott & White Health (The Heart Hospital Baylor Plano), Plano, Texas

Methodist Hospital, San Antonio, Texas

The University of Vermont Medical Center, Burlington, Vermont

University of Virginia Medical Center, Charlottesville, Virginia

Inova Fairfax Hospital, Fairfax, Virginia

Sentara Norfolk General Hospital, Norfolk, Virginia

Saint Mary's Hospital/Bon Secours, Richmond, Virginia

Carilion Roanoke Memorial Hospital, Roanoke, Virginia

Winchester Medical Center, Winchester, Virginia

The Swedish Medical Center Cherry Hill, Seattle, Washington

University of Washington, Seattle, Washington

Providence Sacred Heart Medical Center & Children's Hospital, Spokane, Washington

Aurora St. Luke's Medical Center, Milwaukee, Wisconsin

Royal Columbian Hospital, New Westminster, British Columbia

St. Paul's Hospital, Vancouver, British Columbia

Sunnybrook Health Sciences Centre, Toronto, Ontario

St. Michael's Hospital, Toronto, Ontario

Montreal Heart Insitute, Montreal, Quebec

Glen Royal Victoria Hospital, Montreal, Quebec

Rigshospitalet, Copenhagen, Not set

Conditions: Mitral Valve Regurgitation

Learn More ›

Study of SGR-3515 In Participants With Advanced Solid Tumors.

NCT06463340

Recruiting

The purpose of this study is to learn about the effects of a new study drug, called SGR-3515 that may be a treatment for advanced solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Yale University, Yale Cancer Center, New Haven, Connecticut +13 locations

Conditions: Advanced Solid Tumor

Learn More ›

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

NCT05776069

Recruiting

The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.

Gender:

ALL

Ages:

Between 12 years and 60 years

Trial Updated:

07/29/2025

Locations: Orthopedic Institute for Children (UCLA), Los Angeles, California +24 locations

Orthopedic Institute for Children (UCLA), Los Angeles, California

UC Davis Medical Center, Sacramento, California

University of Colorado School of Medicine, Aurora, Colorado

Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, Georgia

Science 37, Inc., Morrisville, North Carolina

Hemophilia Center of Western PA, Pittsburgh, Pennsylvania

Vanderbilt University Medical Center, Nashville, Tennessee

University of Texas Southwestern, Dallas, Texas

Washington Center for Bleeding Disorders, Seattle, Washington

Versiti Comprehensive Center for Bleeding Disorders, Milwaukee, Wisconsin

Royal Brisbane & Women's Hospital, Queensland Haemophilia Centre, Herston, Queenland

Medical University of Vienna, Vienna, Not set

Hemocentro Unicamp, Campinas, Sao Paulo

Centro de Hemoterapia e Hematologia do Rio de Janeiro HEMORIO, Rio De Janeiro, Not set

Hospital das Clinicas - USP Endereco, São Paulo, Not set

Hamilton Health Sciences Corporation, Hamilton, Ontario

Queens University, Kingston, Ontario

St. Michaels Hospital, Toronto, Ontario

K J Somaiya Super Speciality Hospital & Research Centre, Sion, Mumbai

Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Not set

Queen Elizabeth Hospital Birmingham, Birmingham, Edgbaston

University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire

Royal London Hospital, Clinical Haematology Research, Whitechapel, London

Royal Free Hospital, London, Not set

Imperial College Healthcare NHS Trust- Queen Charlotte's & Chelsea Hospital, London, Not set

Conditions: Von Willebrand Diseases

Learn More ›

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

NCT06047444

Recruiting

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine. A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head, and is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Chronic migraine is defined as having at least 15 days of headache a month with at least 8 of those days being migraine headache days. Migraines are caused by a series of events which cause the brain to get stimulated/activated, which results in the release of chemicals that cause pain. Dysport® is a formulation of Botulinum toxin type A (BoNT-A), a medication that stops the release of these chemical messengers. The study will consist of 3 periods: 1. A 'screening period' of 6 to 12 weeks to assess whether the participant can take part to the study and requires 1 visit. 2. A first Treatment Phase of 24 weeks. On Day 1 and at Week 12 of the first Treatment Phase, participants will receive injections into various muscles across the head, neck, face and shoulders. The injections will contain either a dose "A" or dose "B" of Dysport® or a placebo (an inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or intervention/treatment being studied). Participants will make 4 visits to the clinic in person and have 4 remote (online) visits. 3. A second Treatment Phase of 24 weeks (extension phase). At Week 24 and at Week 36, all participants will get Dysport® (dose "A" or dose "B"). There will be 3 in person visits and 4 remote visits. Participants will need to complete an e-diary and questionnaires throughout the study. Participants will undergo blood samplings, urine collections, physical examinations, and clinical evaluations. They may continue some other medications, but the details need to be recorded. The total study duration for a participant will be up to 60 weeks (approx. 14 months). Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Central Research Associates, Birmingham, Alabama +123 locations

Central Research Associates, Birmingham, Alabama

CCT Research, Phoenix, Arizona

HonorHealth Neurology, Scottsdale, Arizona

Alliance for Multispecialty Research (AMR) Phoenix, Tempe, Arizona

Hope Clinical Research, LLC, Canoga Park, California

Axiom Research LLC, Colton, California

Fullerton Neurological Center, Fullerton, California

Neurology Center of North Orange County, Fullerton, California

The Los Angeles Headache Center, Los Angeles, California

SDS Clinical Trials, Orange, California

840011, Palo Alto, California

Stanford University School of Medicine - Stanford Cardiovascular Institute (CVI), Palo Alto, California

Alliance Clinical San Diego (Acclaim Clinical Research), San Diego, California

University of Colorado Hospital - Neurology Clinic, Aurora, Colorado

Yale University School of Medicine, East Hartford, Connecticut

Hasbani Neurology, New Haven, Connecticut

Visionary Investigators Network (VIN), Aventura, Florida

Velocity Clinical Research - Hallandale Beach, Hallandale Beach, Florida

AGA Clinical Trials, Hialeah, Florida

Infinity Clinical Research, LLC, Hollywood, Florida

Neurology Clinical Research, Inc., Hollywood, Florida

Clinical Neuroscience Solutions Healthcare, Inc (CNS Healthcare, INC), Jacksonville, Florida

University of Miami Leonard M. Miller School of Medicine - Professional Arts Center, Miami, Florida

Clinical Neuroscience Solutions, Inc ((CNS Healthcare) - Psychiatry), Orlando, Florida

Guardian Angel Research Center, Tampa, Florida

USF Health-Morsani Center, Tampa, Florida

Conquest Research, Winter Park, Florida

Headache Wellness Center, Greensboro, Georgia

Velocity Clinical Research - Savannah Neurology Specialists, Savannah, Georgia

Cedar Crosse Research Center, Chicago, Illinois

Chicago Headache Center & Research, Chicago, Illinois

Robbins Headache Clinic, Riverwoods, Illinois

MD Fort Wayne Neurological Center, Fort Wayne, Indiana

CenExel iResearch Atlanta, LLC, Frederick, Maryland

Comprehensive Neurology Services, Frederick, Maryland

Boston Clinical Trials Inc, Boston, Massachusetts

Beth Israel Deaconess Medical Center - Arnold Pain Management, Brookline, Massachusetts

Neurology Center of NE,PC - Neurology, Foxboro, Massachusetts

Mass Institute of Clinical Research, Westborough, Massachusetts

New England Regional Headache Center, Inc., Worcester, Massachusetts

Quest Research Institute, Farmington Hills, Michigan

Minneapolis Clinic of Neurology, Burnsville, Minnesota

Clinical Research Professionals, Chesterfield, Missouri

Papillion Research Center, Papillion, Nebraska

Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas, Nevada

Neurology Center of Las Vegas - Neurology, Las Vegas, Nevada

Dent Neurosciences Research Center, Inc., Amherst, New York

SPRI Clinical Trials, LLC, Brooklyn, New York

Nuvance Health Medical Practice, Poughkeepsie, New York

Rochester Clinical Research, Rochester, New York

Duke University Medical Center, Durham, North Carolina

Blue Sky MD, Hendersonville, North Carolina

Headache Center of Hope, Cincinnati, Ohio

The Orthopedic Foundation - Clinic, New Albany, Ohio

Helios Clinical Research, Wooster, Ohio

Providence Neurological Specialties West, Portland, Oregon

Suburban Research Associates, Media, Pennsylvania

Thomas Jefferson University Hospital - Jefferson Hospital for Neuroscience - Jefferson Neurology Associates - Neurology, Philadelphia, Pennsylvania

Coastal Carolina Research Center - North Charleston, North Charleston, South Carolina

Neurology Clinic, PC, Cordova, Tennessee

KCA Neurology, PLLC, Franklin, Tennessee

Helios Clinical Research LLC (Helios CR, Inc. Jackson TN), Jackson, Tennessee

Herzog, Steven MD, Dallas, Texas

Texas Neurology, Dallas, Texas

Zenos Clinical Research, Dallas, Texas

North Texas Institute of Neurology & Headache, Frisco, Texas

Lone Star Neurology, Frisco, Texas

Clinical Trial Network, Houston, Texas

Research Your Health, Plano, Texas

J. Lewis Research Inc.-Foothill, Salt Lake City, Utah

Metrodora Institute, West Valley City, Utah

Inova Medical Group - Neurology, Fairfax, Virginia

MedStar Health - Department of Neurology, Columbia, Washington

Frontier Clinical Research, LLC, Kingwood, West Virginia

Centricity Research Halifax Multispecialty, Halifax, Not set

Genge Partners Inc., Montréal, Not set

CARe Clinic-Calgary, Red Deer, Not set

Bluewater Clinical Research Group Inc., Sarnia, Not set

Royal Julilee Hospital, Victoria, Not set

Neurologie Brno s.r.o., Brno, Not set

Pratia Brno s.r.o., Brno, Not set

NeuropsychiatrieHK, s.r.o., Hradec Králové, Not set

Nemocnice Jihlava, p.o., Jihlava, Not set

Fakultni nemocnice Ostrava, Ostrava - Poruba, Not set

Fakultni Thomayerova nemocnice, Praha 4, Not set

Axon Clinical, s.r.o., Praha 5, Not set

Institut neuropsychiatricke pece, Praha 8, Not set

DADO MEDICAL s.r.o., Praha, Not set

Ltd "Health", Batumi, Not set

ISR-GEO Med Res Clin Healthycore, Tbilisi, Not set

"Pineo Medical Ecosystem" LTD, Tbilisi, Not set

LTD New Hospitals, Tbilisi, Not set

LTD S.Khechinashvili University Hospital, Tbilisi, Not set

Multprofil Clinic Consilium Medulla, Tbilisi, Not set

Charité - Universitätsmedizin Berlin KöR, Berlin, Not set

Emovis GmbH, Berlin, Not set

Universitätsmedizin Greifswald, Greifswald, Not set

Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB, Haag In Oberbayern, Not set

Vitos Orthopaedische Klinik Kassel, Kassel, Not set

LMU - Klinikum der Universität München - Campus Grosshadern, München, Not set

Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL di Bologna, Bologna, Not set

Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, Napoli, Not set

IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione, Pavia, Not set

Istituto Neurologico Mediterraneo - NEUROMED, Istituto di Ricovero e Cura a Carattere Scientifico, Pozzilli, Not set

IRCCS San Raffaele Pisana, Roma, Not set

PU Campus Bio-Medico di Roma, Roma, Not set

Centrum Medyczne Neuromed Pawel Lisewski, Bydgoszcz, Not set

Synexus Polska Sp. z o.o., Gdynia, Not set

Centrum Medyczne Pratia Katowice, Katowice, Not set

Krakowska Akademia Neurologii Sp. z o.o., Kraków, Not set

Krakowskie Centrum MedyczneSp.z o.o, Kraków, Not set

Pratia MCM Krakow, Kraków, Not set

Indywidualna Praktyka Lekarska dr hab. med. Anna Szczepanska-Szerej, Lublin, Not set

Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K., Oswiecim, Not set

Hospital Universitario Reina Sofia, Córdoba, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario Regional De Malaga, Málaga, Not set

Hospital Universitario Virgen De La Macarena, Sevilla, Not set

Hospital Clinico Universitario De Valencia, Valencia, Not set

Hospital Universitario y Politécnico La Fe, Valencia, Not set

Hospital Clinico Universitario Lozano Blesa, Zaragoza, Not set

University Hospitals Sussex NHS Foundation Trust - Royal Sussex County Hospital, Brighton, Not set

King's College Hospital (KCH) NHS Foundation Trust, Brixton, Not set

Conditions: Chronic Migraine

Learn More ›

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Recruiting

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 2 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).

Gender:

ALL

Ages:

Between 18 years and 85 years

Trial Updated:

07/29/2025

Locations: Gastro Care Institute, Lancaster, California +141 locations

Gastro Care Institute, Lancaster, California

IHS Health Research, Kissimmee, Florida

Louisiana Research Center, Shreveport, Louisiana

Wake Research Associates, Raleigh, North Carolina

Palmetto Gastroenterology Clinical Research, Summerville, South Carolina

Gastrointestinal Associates of Northeast Tennessee, Johnson City, Tennessee

GI Alliance - Cedar Park, Cedar Park, Texas

The University of Texas Health Science Center at Houston, Houston, Texas

Texas Digestive Disease Consultants, San Marcos, Texas

Tyler Research Institute, LLC, Tyler, Texas

Care Access Research - Ogden, Ogden, Utah

Gastroenterology Associates of Central Virginia, Lynchburg, Virginia

Medical University Hematology, Innsbruck, Tyrol

Salzburg Regional Hospital, Salzburg, Not set

University Hospital St. Poelten, St. Poelten, Not set

Medical University of Vienna, Vienna, Not set

Pesquisare, Santo Andre, Sao Paulo

Chronos Pesquisa Clínica, Brasília, Not set

Clínica Hepatogastro JK, São Paulo, Not set

University of Calgary, Calgary, Alberta

Mount Sinai Hospital, Chicago, IL

St Joseph'S Health Centre Toronto, Toronto, Ontario

Toronto Digestive Disease Associates, Inc., Vaughan, Ontario

Hopital Maisonneuve-Rosemont, Montreal, Quebec

Nova Scotia Health Authority, Halifax, Not set

London Health Sciences Centre, London, Not set

Diex Recherche Quebec Inc., Quebec, Not set

Hospital Pablo Tobon Uribe, Medellín, Antioquia

Fundación Valle del Lili, Cali, Valle Del Cauca

Cardiomet Cequin S.A.S., Research Unit, Armenia, Not set

Cardiovascular Foundation of Colombia, Floridablanca, Not set

Corporation for Health Studies "CES", Medellin, Not set

Northern University Foundation Hospital, Soledad, Not set

Poliklinika Solmed, Zagreb, Grad Zagreb

Poliklinika Borzan, Osijek, Not set

Specialty hospital Medico Rijeka, Rijeka, Not set

Virovitica General Hospital, Virovitica, Not set

General Hospital Zadar, Zadar, Not set

SurGal Clinic s.r.o., Brno, Not set

Military Hospital Brno,, Brno, Not set

Clinoxus s.r.o., Outpatient Clinic Budejovicka, Prague, Not set

Axon Clinical, s.r.o., Praha 4, Not set

Hospices Civils de Lyon - Lyon Sud, Pierre-Benite, Not set

CHU de Saint-Etienne, Saint Etienne Cedex 02, Not set

CHRU Nancy Brabois - Hôpital d'Enfants, Vandoeuvre les Nancy, Not set

High Technology Hospital Medcenter LLC, Batumi, Not set

Emergency Cardiology Center by Academician G. Chapidze LLC, Tbilisi, Not set

LTD Institute of Clinical Cardiology, Tbilisi, Not set

LTD Aversi Clinic, Tbilisi, Not set

LEPL The First University Clinic of Tbilisi State Medical University, Tbilisi, Not set

LTD The First Medical Center, Tbilisi, Not set

University Hospital Ulm, Ulm, Baden-Wuerttemberg

Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg

Charite - University Hospital Berlin, Berlin, Not set

emovis GmbH - Futuremeds, Berlin, Not set

DRK Clinic Berlin-Koepenick, Berlin, Not set

Medical Care Unit Dachau, Dachau, Not set

Sana Hospital Duisburg, Duisburg, Not set

University Hospital Halle (Saale), Halle, Not set

University Hospital Schleswig-Holstein, Kiel, Not set

Group Practice Jakobeit, Wipperfuerth, Not set

Markhot Ferenc Oktatókórház, Eger, Heves

Bekes Megyei Kozponti Korhaz Dr. Rethy Pal Tagkorhaz IV. Belgyogyaszat, Bekescsaba, Not set

Semmelweis Medical University, Budapest, Not set

Bugat Pal Hospital Gyongyos, Gyongyos, Not set

Fejer County St. Gyorgy University Teaching Hospital, Szekesfehervar, Not set

CLINFAN Szolgáltató Kft, Szekszard, Not set

Yashoda Hospital, Secunderabad, Andhra Pradesh

Shree Giriraj Multispeciality Hospital, Rajkot, Gujarat

Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala

SMS Medical College Hospital, Jaipur, Rajasthan

S R Kalla Memorial Gastro and General Hospital, Jaipur, Sardar Patel Marg

Apollo Cancer Centre, Chennai, Tamil Nadu

Navneet Memorial Hospital SUSHRUSHA, Ahmedabad, Not set

Noble Hospital Pvt Ltd, Pune, Not set

Prime Institute of Digestive Sciences, Rajkot, Not set

IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG

Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio

IRCCS Policlinico San Donato, San Donato Milanese, Milano

Policlinico S. Orsola-Malpighi, Bologna, Padiglione 19

Ospedale Sacro Cuore Don G. Calabria, Negrar, Verona

IRCCS San Raffaele, Milano, Not set

Big Metropolitan Hospital Niguarda Regional Health Authority, Milan, Not set

IRCCS Istituto Clinico Humanitas- Centro Malattie Infiammatorie Intestinali, Rozzano, Not set

Ospedale Santa Maria della Misericordia, Clinica Ematologica ASUFC (Azienda Sanitaria Universitaria Friuli Centrale), Udine, Not set

Scientific Research Institute of Cardiology and Internal Disease of the Ministry of Health of the Republic of Kazakhstan, Almaty, Not set

National Research Medical Center, Astana, Not set

Sana Clinic, Astana, Not set

Karaganda Medical University, Karaganda, Not set

Semey Medical University, Semey, Not set

"Gastromed" Medical Center, Shymkent, Not set

Diagnostic Center of Shymkent, Shymkent, Not set

Liepaja Regional Hospital, Liepaja, Not set

Pauls Stradins Clinical Univeristy Hospital, Riga, Not set

Centro de Estudios Clínicos de Querétaro (CECLIQ), Queretaro, Querétaro

Applied Neuroscience Research Institute A.C., Durango, Not set

Synexus Polska Sp. z o.o., Wroclaw, Dolnośląskie

WIP Warsaw IBD Point Profesor Kierkus, Warsaw, Mazowieckie

Synexus Polska Sp. z o.o. Oddzial w Warszawie, Warszawa, Mazowieckie

AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Gdansku, Gdańsk, Pomorskie

"MEDIS" Medical Center, Bydgoszcz, Not set

Non-public Health Care Center KERmed Medical Centre, Bydgoszcz, Not set

CLINSANTE Clinical Research Centre Ewa Galczak-Nowak, Malgorzata Trzaska, Bydgoszcz, Not set

Synexus Polska Sp. Z o.o. Branch in Czestochowa, Czestochowa, Not set

St. John Paul 2nd Municipal Hospital in Elblag, Elblag, Not set

"Vita Longa" Non-Public Healthcare Facility, Limited Liability Company, Katowice, Not set

PLEJADY Medical Centre, Krakow, Not set

"Landa" Specialist Doctor's Offices, Krakow, Not set

Twoja Przychodnia Medical Centre of Opole, Opole, Not set

EMC Medical Institute Joint Stock Company, "Certus" Private Healthcare Facility Hospital No. 1, Poznan, Not set

Synexus Polska Sp. z o.o. Branch in Poznan, Poznan, Not set

Endoskopia Sp. z.o.o., Sopot, Not set

Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Not set

H-T. Medical Center, Tychy, Not set

MDM Healthcare Centre, Warsaw, Not set

WSD Medi, Warsaw, Not set

Medical Centre Oporow, Wroclaw, Not set

Synexus Polska - Katowicach, Katowice, Śląskie

"Sfanta Vineri" Medical Center, Bucharest, Not set

Monza Oncology Hospital SRL, Bucharest, Not set

Colentina Clinical Hospital, Bucharest, Not set

Oncohelp Association, Timisoara, Not set

Zvezdara University Medical Center, Belgrade, Not set

Clinical Center " Dr Dragisa Misovic Dedinje", Belgrade, Not set

Clinical Hospital Center Bezanijska Kosa, Belgrade, Not set

Clinical Center Kragujevac, Kragujevac, Not set

General Hospital Leskovac, Leskovac, Not set

Clinical Center of Vojvodina, Novi Sad, Not set

General Hospital Uzice, Uzice, Not set

General Hospital "Djordje Joanovic", Zrenjanin, Not set

Cliniq s.r.o., Bratislava, Bratislavský Kraj

ENDOMED s.r.o., Kosice, Not set

GASTRO I., s.r.o., Presova, Not set

Gastro LM s.r.o., Presov, Not set

Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval, Ferrol, A Coruña [La Coruña]

Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Lleida [Lérida]

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

University and Polytechnic Hospital La Fe, Valencia, Not set

Conditions: Inflammatory Bowel Diseases, Crohn's Disease

Learn More ›

Anesthetics and Analgesics in Children

NCT03427736

Recruiting

The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.

Gender:

ALL

Ages:

Between 0 years and 17 years

Trial Updated:

07/29/2025

Locations: Lucile Packard Children's Hospital, Stanford, California +12 locations

Conditions: Anesthesia, Pain

Learn More ›

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

NCT06297993

Recruiting

Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

Gender:

ALL

Ages:

Between 18 years and 75 years

Trial Updated:

07/29/2025

Locations: UC Davis, Sacramento, California +9 locations

Conditions: PSC

Learn More ›

PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

NCT05756244

Recruiting

The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

Gender:

FEMALE

Ages:

Between 18 years and 60 years

Trial Updated:

07/29/2025

Locations: Duke University Hospital, Durham, North Carolina +9 locations

Conditions: Pregnancy Related, Venous Thromboembolism

Learn More ›

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

Recruiting

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Gender:

ALL

Ages:

Between 18 years and 65 years

Trial Updated:

07/29/2025

Locations: City of Hope, Duarte, California +28 locations

City of Hope, Duarte, California

University of California San Francisco, San Francisco, California

UHealth Diabetes Research Institute, Miami, Florida

Northwestern Organ Transplant Center, Chicago, Illinois

University of Chicago, Chicago, Illinois

Johns Hopkins University, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center Montefiore, Pittsburgh, Pennsylvania

Baylor Scott and White Research Institute, Dallas, Texas

VCU Medical Center, Richmond, Richmond, Virginia

University of Wisconsin, Madison, Wisconsin

University of Alberta, Edmonton, Edmonton, Not set

McGill University Health Centre, Montreal, Not set

Toronto General Hospital (TGH), Toronto, Not set

Vancouver General Hospital, Vancouver, Not set

CHU Lille, Lille, Not set

Centre de recherche en Biomédecine de Strasbourg, Strasbourg, Not set

Dresden Center for Islet Transplantation, Dresden, Not set

IRCCS Ospedale San Raffaele, Milan, Not set

Leiden University, Leiden, Not set

Oslo University Hospital, Oslo, Not set

King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology, Riyadh, Not set

King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology, Riyadh, Not set

Hopiteaux Universitaires de Geneve, Geneve, Not set

Churchill Hospital, Headington, Oxford

Royal Infirmary of Edinburgh, Edinburgh, Not set

Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, Not set

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Not set

Conditions: Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

Learn More ›